SCHEMBL29494309

SCHEMBL29494309

Cc1ccc(NS(=O)(=O)C2CC2)cc1C(=O)N[C@H](C)c1cccc2ccccc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29494305 0.95 — —
SCHEMBL31360256 0.87 — —
SCHEMBL25155494 0.87 — —
SCHEMBL30344389 0.87 — —
SCHEMBL29494318 0.86 — —
SCHEMBL29494331 0.85 — —
SCHEMBL29494290 0.84 — —
SCHEMBL29494268 0.84 — —
SCHEMBL29494402 0.84 — —
SCHEMBL29494236 0.83 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022070048-A1 NOVEL AMIDE DERIVATIVES CADILA HEALTHCARE LIMITED (IN) 2022-04-07 — — WO claimed
WO-2022070048-A1 NOVEL AMIDE DERIVATIVES CADILA HEALTHCARE LIMITED (IN) 2022-04-07 — — WO disclosed
Send feedback